OTOLITH LABS
Otolith Labs has developed a novel wearable medical device that is on track to be the first FDA approved device for the treatment of vertigo through the De Novo process in 2023. The technology provides immediate relief of symptoms in approximately 80% of vertigo cases based on pilot clinical data. Otolith Labs has received $1.8 million in contracts from the US Department of Defense to further develop the technology for their personnel needs.
OTOLITH LABS
Industry:
Consumer Electronics Hardware Medical Medical Device Military Therapeutics
Founded:
2015-01-15
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.otolithlabs.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Google Maps WordPress 6.0
Current Employees Featured
Founder
Investors List
Morningside Venture Partners
Morningside Venture Partners investment in Series A - Otolith Labs
Radical Investments LP
Radical Investments LP investment in Seed Round - Otolith Labs
Official Site Inspections
http://www.otolithlabs.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.5 K
- Host name: 57.0.153.160.host.secureserver.net
- IP address: 160.153.0.57
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Otolith Labs"
About | Otolith.com
Otolith Labs is pioneering the first medical wearable for the treatment of chronic vertigo, a symptom experienced by 11.6 million Americans. Otolith’s patented non-invasive head-worn …See details»
Otolith Labs - Crunchbase Company Profile & Funding
Contact Email [email protected] Otolith Labs develops a therapeutic device for the treatment of vertigo. It is a non-invasive wearable medical device powered by science, data, and clinical research designed to treat vertigo and vestibular …See details»
Otolith Labs Company Profile | Management and Employees List
[email protected]: Otolith Labs Top Competitors. Company Employees Revenue Top technologies; Labyrinth Devices LLC. 8: $1.9 M: Clinical Trial Data Services. 13: $5.4 M: …See details»
Otolith Company Profile 2024: Valuation, Funding
Otolith General Information Description. Developer of a non-invasive wearable device designed for managing vertigo symptoms. The company's device utilizes tuned vibrations to interact with the motion sensors in the inner ear, mitigating …See details»
Otolith Labs - LinkedIn
Otolith Labs is the world-leader in vestibular masking technology. We build noninvasive wearable medical devices powered by science, data, and clinical research for the treatment of vertigo …See details»
Otolith Labs Information - RocketReach
Otolithlabs.com; 5+ 214695XXXX; 972691XXXX; 214289XXXX; 972742XXXX; 214245XXXX; 484499XXXX; Brooke Wilson Biomedical Engineer at Otolith Labs Washington, DC, US View. …See details»
Otolith Labs - Overview, News & Similar companies - ZoomInfo
View Otolith Labs (www.otolithlabs.com) location in District of Columbia, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Otolith Labs - Craft
Otolith Labs has 5 employees at their 1 location and $23.3 m in total funding,. See insights on Otolith Labs including office locations, competitors, revenue, financials, executives, …See details»
Otolith Labs (USA) Funding: $25.7M - medicalstartups.org
Country: USA | Funding: $25.7M Website: https://www.otolithlabs.com/ First Therapeutic Device For The Treatment Of Vertigo.See details»
Otolith Labs - Mark Cuban
Otolith Labs. Otolith Labs pioneered the science behind non-invasive Vestibular System Masking (nVSM), a novel approach for treating conditions related to the inner ear.See details»
Otolith Labs - Mark Cuban Companies
Otolith Labs. Otolith Labs pioneered the science behind non-invasive Vestibular System Masking (nVSM), a novel approach for treating conditions related to the inner ear.See details»
ADDING and REPLACING - Business Wire
Jun 24, 2021 Sam Owen, CEO, (202) 903-0900, [email protected] Release Summary Otolith Announces $3.3 M in Seed Financing; Receives “Breakthrough Device” Designation …See details»
Breakthrough Press Release | Otolith.com
WASHINGTON, D.C., June 24, 2021 — Otolith Labs, launched at the Halcyon Incubator, announced today it has received U.S. Food and Drug Administration (FDA) BREAKTHROUGH …See details»
Otolith lab study? Anyone hear of this or try this?? It’s ... - Reddit
Meniere’s Disease is a disease of the inner ear. The cause is unknown, there is no known effective treatment or cure at this time. Meniere’s is characterized by four main symptoms, …See details»
News & Recognition | Otolith.com
Otolith Labs Announces $20 Million Series A Financing. Otolith Receives Breakthrough Device Designation from FDA. Otolith Receives ISO 13485 Certification for Medical Devices Quality …See details»
Sam Owen Bio | Otolith.com
Sam Owen has spent over six years working with acoustics and acceleration sensors, leading to the development of Otolith’s patented non-invasive Vestibular Resonance Therapy (nVRT) …See details»
Otolith Labs introduces The Otoband - Apple Podcasts
Vestibular Specialists Dr. Danielle Tolman, PT and Dr. Abbie Ross, PT, NCS are joined by Sam Owen and Dr. Didier Depireux, Ph.D to talk about their company Otolith Labs and the device …See details»
Clinical Studies | Otolith.com
Our rotary chair study is being conducted at the Dizzy & Vertigo Institute of Los Angeles and the Medical University of Southern Carolina. If you live in CA or SC and are interested in the …See details»
nVRT Technology | Otolith.com
Otolith’s device is a wearable medical device with FDA Breakthrough Designation. Utilizing our non-invasive Vestibular Resonance Therapy or nVRT technology — the Otolith device …See details»